All Articles by Author:

Britya Ghosh

Hypoxia Promotes Glioma Stem Cell Proliferation by Enhancing the 14-3-3β Expression via the PI3K Pathway

[Journal of Immunology Research] Hypoxia induced by using CoCl2 application and 14-3-3β protein knockdown by specific small interfering RNA transfection were performed in GSCs both in vitro and in vivo to observe their role in glioma progression and metastasis occurrence by using western blot analysis and MTT assay.

Reflected Stemness as a Potential Driver of the Tumor Microenvironment

[Trends in Cell Biology] Investigators suggested that focusing on the early interaction between stem cells harbouring mutations in cancer-driver genes and the surrounding tissue cells, which might also carry genetic mutations, might hold the key to this understanding.

Foghorn Therapeutics Provides Update on Phase I Study of FHD-286 in Relapsed and/or Refractory AML and MDS

[Foghorn Therapeutics, Inc. (BioSpace, Inc.)] Foghorn Therapeutics Inc. announced the FDA has placed the Phase I dose escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia and myelodysplastic syndrome on a partial clinical hold.

Inhibition of Mitochondrial Complex I Reverses NOTCH1-Driven Metabolic Reprogramming in T-cell Acute Lymphoblastic Leukemia

[Nature Communications] Researchers identified oxidative phosphorylation as a critical pathway for leukemia cell survival and demonstrate a direct relationship between NOTCH1, elevated OxPhos gene expression, and acquired chemoresistance in pre-leukemic and leukemic models.

Inability to Phosphorylate Y88 of p27Kip1 Enforces Reduced p27 Protein Levels and Accelerates Leukemia Progression

[Leukemia] To investigate the physiological significance of p27 tyrosine phosphorylation, scientists generated a knock-in mouse model where Y88 was replaced by phenylalanine.

Developmental Cues License Megakaryocyte Priming in Murine Hematopoietic Stem Cells

[Blood Advances] The authors identified LIN28B known for its role in promoting fetal-like self-renewal, as an insulator against the establishment of a megakaryocyte biased hematopoietic stem cell pool.

Popular

Survival Outcomes of Apalutamide as a Starting Treatment: Impact in Real-World Patients With Metastatic Hormone Sensitive Prostate Cancer (OASIS)

[Prostate Cancer and Prostatic Diseases] Scientists evaluated the impact of upfront therapy for metastatic hormone-sensitive prostate cancer on outcomes in real-world clinical practice in the United States.

A TBX2-Driven Signaling Switch From Androgen Receptor to Glucocorticoid Receptor Confers Therapeutic Resistance in Prostate Cancer

[Oncogene] Using human prostate cancer and CRPC cell line models, scientists demonstrated that TBX2 downregulated androgen receptor and upregulated glucocorticoid receptor through direct transcriptional regulation.

Radiotherapy-Resistant Prostate Cancer Cells Escape Immune Checkpoint Blockade through the Senescence-Related Ataxia Telangiectasia and Rad3-Related Protein

[Cancer Communications] Scientists identified a subset of prostate cancer cells that exhibited resistance to radiotherapy, characterized by a reduced antigen presentation capability, which enhanced their ability to evade immune detection and resist cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade.